Seeing Is Believing
Currently out of the existing stock ratings of Gaurav Rateria, 2 are a HOLD (50%), 1 are a SELL (25%), 1 are a BUY (25%).
Analyst Gaurav Rateria, currently employed at MORGAN STANLEY, carries an average stock price target met ratio of 100% that have a potential upside of 11.6% achieved within 116 days.
Gaurav Rateria’s has documented 8 price targets and ratings displayed on 4 stocks. The coverage is on Technology, Consumer Cyclical sectors.
Most recent stock forecast was given on MMYT, MakeMyTrip at 08-Dec-2022.
Analyst best performing recommendations are on G (GENPACT).
The best stock recommendation documented was for G (GENPACT) at 1/15/2019. The price target of $28 was fulfilled within 20 days with a profit of $2.01 (7.73%) receiving and performance score of 3.87.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 21-Apr-2020
$20
$5.28 (35.87%)
$18
6 months 24 days ago
(24-Jul-2025)
13/16 (81.25%)
$2.32 (13.12%)
271
Hold Since 14-Apr-2025
$19
$4.28 (29.08%)
$18
6 months 24 days ago
(24-Jul-2025)
7/11 (63.64%)
$1.32 (7.47%)
198
Hold Since 13-Apr-2017
$18
$3.28 (22.28%)
$18
6 months 25 days ago
(23-Jul-2025)
7/7 (100%)
$-0.45 (-2.44%)
79
Hold Since 13-Apr-2017
$17
$2.28 (15.49%)
$18
9 months 27 days ago
(21-Apr-2025)
7/8 (87.5%)
$0.65 (3.98%)
257
Buy Since 03-Jan-2024
$21.1
$6.38 (43.34%)
$27.4
10 months ago
(17-Apr-2025)
1/5 (20%)
$5.19 (32.62%)
76
What Year was the first public recommendation made by Gaurav Rateria?